Joseph Edward Johnson, Pachaimuthu Elango, Arokyamuthu Vasukinathan, Muthukrishnan Muthushenbagam, Kannan Dinesh Kumar, Dhanalakshmi B
Department of Anaesthesiology, Kanyakumari Government Medical College and Hospital, Kanyakumari, Tamil Nadu, India.
Indian J Anaesth. 2015 Jul;59(7):406-10. doi: 10.4103/0019-5049.160933.
Episure™ AutoDetect™ syringe (EAS), a spring-loaded syringe, is a new loss-of-resistance syringe used to identify epidural space. It has an advantage of subjective and objective confirmation in identifying epidural space over glass syringe (GS) for beginners. We compared the performance of EAS with that of GS for identifying epidural space in lower thoracic epidurals.
A total of 120 American Society of Anesthesiolgists I-II patients aged 18-60 years requiring lower thoracic epidural analgesia for surgery were randomised into Group I (EAS): Epidural identified using EAS and Group II (GS) epidural identified with GS. Patient demographic data, depth to epidural space (cm), number of attempts, time to locate epidural space (s), inadvertent dural puncture and failed epidural analgesia were the parameters noted.
There were no differences in patient demographics or depth to the epidural space between the two groups. There were five failed blocks in the GS group and none in the EAS group (P = 0.0287). Similarly, there were five inadvertent dural punctures in the GS group and none in the EAS group (P = 0.0287). When epidural was identified in fewer attempts, the time needed to identify epidural space was quicker with EAS (P = 0.0012).
Using EAS allowed reliable and quick identification of the epidural space in lower thoracic epidural technique as compared to use of glass syringe. There was no incidence of inadvertent dural puncture or failed blocks with the EAS.
Episure™自动检测™注射器(EAS)是一种弹簧式注射器,是用于识别硬膜外腔的新型阻力消失注射器。对于初学者而言,在识别硬膜外腔方面,它比玻璃注射器(GS)具有主观和客观确认的优势。我们比较了EAS与GS在识别下胸段硬膜外腔方面的性能。
总共120例年龄在18至60岁之间、因手术需要进行下胸段硬膜外镇痛的美国麻醉医师协会I-II级患者被随机分为I组(EAS组):使用EAS识别硬膜外腔;II组(GS组):使用GS识别硬膜外腔。记录患者的人口统计学数据、至硬膜外腔的深度(厘米)、穿刺次数、定位硬膜外腔的时间(秒)、意外硬膜穿破和硬膜外镇痛失败情况等参数。
两组患者的人口统计学数据或至硬膜外腔的深度无差异。GS组有5例阻滞失败,EAS组无阻滞失败(P = 0.0287)。同样,GS组有5例意外硬膜穿破,EAS组无意外硬膜穿破(P = 0.0287)。当以较少的穿刺次数识别出硬膜外腔时,EAS识别硬膜外腔所需的时间更快(P = 0.0012)。
与使用玻璃注射器相比,使用EAS在进行下胸段硬膜外技术时能够可靠且快速地识别硬膜外腔。使用EAS没有发生意外硬膜穿破或阻滞失败的情况。